118 results
SD
EX-1.01
NVRO
Nevro Corp
30 May 24
Conflict minerals disclosure
4:55pm
, an evidence-based neuromodulation platform for the treatment of chronic pain. We have commercialized four different generations of the Senza product: Senza
8-K
EX-99.1
NVRO
Nevro Corp
7 May 24
Nevro Reports First-Quarter 2024 Financial Results
4:11pm
solutions for the treatment of chronic pain, today reported its first quarter 2024 financial results. The company also announced additional … efficiencies, expand margins and continue to focus on delivering innovative treatment therapies for patients suffering from chronic pain,” Thornal added
8-K
EX-99.1
4u8j2q7h4knp9
21 Feb 24
Nevro Enters Into Cooperation Agreement With Engaged Capital
4:11pm
8-K
EX-99.1
jeqi4zf g4m7
21 Feb 24
Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results
4:09pm
424B3
zvd7c351s0vb8o27wh
10 Jan 24
Prospectus supplement
5:26pm
8-K
EX-99.1
uyet6x
9 Jan 24
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results
8:41am
S-3
mhl6bt
28 Dec 23
Shelf registration
6:40pm
8-K
EX-99.1
k2ocfwcs2bcx3kja8
1 Dec 23
Nevro Announces Acquisition of Vyrsa™ Technologies
6:07am
8-K
EX-99.1
t6gsbtk8i0s9s6vg wyt
1 Nov 23
Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance
4:07pm
8-K
EX-99.1
r2yla5 i4a0x
1 Aug 23
Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance
4:10pm
SD
EX-1.01
ok2jriuqg4wtgt4j
23 May 23
Conflict minerals disclosure
5:04pm
8-K
EX-99.1
zkm0 smf391xdnp
26 Apr 23
Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance
4:13pm
8-K
EX-99.1
zs0nm38g0s2yeqa9a 0c
19 Apr 23
Results of Operations and Financial Condition
5:07pm